Back

Differential causative effects of germline pathogenic variants in MUTYH and PALB2 in a patient with colorectal polyposis and breast cancer

Camacho Valenzuela, J.; Pelletier, D.; Polak, P.; Fu, L.; Hamel, N.; Domecq, C.; Ahmed, A.; Robles-Espinoza, C. D.; Foulkes, W. D.

2026-05-25 genetic and genomic medicine
10.64898/2026.05.15.26352890 medRxiv
Show abstract

Purpose Patients carrying Germline Pathogenic Variants (GPVs) in multiple cancer susceptibility genes (CSGs) can be described within the context of Multi-locus Inherited Neoplasia Allele Syndrome (MINAS). The role of each GPV is typically interpreted based on clinical phenotypes. Here, we used tumor sequencing, particularly mutational signatures, to investigate the contribution of GPVs in MUTYH and PALB2 to colorectal polyposis and breast cancer in a single patient at a molecular level. Methods We analyzed tumor sequencing data, including mutational signatures and genomic scars, of a breast tumor and a colorectal polyp from a patient with biallelic GPVs in MUTYH and a heterozygous GPV in PALB2. Results The colorectal polyp showed a dominant contribution of MUTYH-associated Base Excision Repair deficiency (BERd) mutational signatures, with no evidence of Homologous Recombination Repair Deficiency (HRD). In contrast, the breast tumor showed both MUTYH-driven BERd and HRD-associated signatures, including SBS3, ID6 and an elevated HRD score, despite the absence of a detectable second hit in PALB2. These findings suggest a differential contribution from the CSGs, with MUTYH contributing to both lesions and PALB2 contributing specifically to the breast tumor. The observed pattern does not align with the additive or synergistic models described in MINAS. Conclusions Our study provides evidence that mutational signatures can elucidate the contribution of multiple CSGs to tumorigenesis within a single patient. These findings extend current interpretations of MINAS beyond additive or synergistic phenotypes, which may help to better understand tumor etiology, with potential clinical implications, including eligibility for targeted therapies.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Genetics in Medicine
69 papers in training set
Top 0.1%
18.4%
2
Human Mutation
29 papers in training set
Top 0.1%
17.3%
3
Journal of Medical Genetics
28 papers in training set
Top 0.1%
7.1%
4
npj Genomic Medicine
33 papers in training set
Top 0.1%
6.3%
5
Scientific Reports
3102 papers in training set
Top 20%
6.2%
50% of probability mass above
6
Genome Medicine
154 papers in training set
Top 2%
4.3%
7
The Journal of Molecular Diagnostics
36 papers in training set
Top 0.1%
4.2%
8
European Journal of Human Genetics
49 papers in training set
Top 0.2%
3.9%
9
Cancers
200 papers in training set
Top 2%
3.5%
10
Cancer Epidemiology, Biomarkers & Prevention
17 papers in training set
Top 0.3%
1.9%
11
The American Journal of Human Genetics
206 papers in training set
Top 3%
1.2%
12
Cell Genomics
162 papers in training set
Top 5%
0.9%
13
Pigment Cell & Melanoma Research
11 papers in training set
Top 0.1%
0.9%
14
GENETICS
189 papers in training set
Top 1%
0.9%
15
Genes
126 papers in training set
Top 2%
0.9%
16
Human Genetics and Genomics Advances
70 papers in training set
Top 0.7%
0.8%
17
Genetics in Medicine Open
10 papers in training set
Top 0.1%
0.8%
18
PLOS Genetics
756 papers in training set
Top 15%
0.7%
19
Gut
36 papers in training set
Top 0.9%
0.7%
20
iScience
1063 papers in training set
Top 33%
0.7%
21
Journal of Clinical Medicine
91 papers in training set
Top 7%
0.7%
22
Frontiers in Genetics
197 papers in training set
Top 10%
0.7%
23
PLOS ONE
4510 papers in training set
Top 69%
0.7%
24
Human Molecular Genetics
130 papers in training set
Top 4%
0.6%
25
eClinicalMedicine
55 papers in training set
Top 2%
0.6%
26
Modern Pathology
21 papers in training set
Top 0.6%
0.6%
27
American Journal of Medical Genetics Part A
17 papers in training set
Top 0.4%
0.6%
28
Frontiers in Molecular Biosciences
100 papers in training set
Top 6%
0.6%
29
JCO Precision Oncology
14 papers in training set
Top 0.5%
0.6%